1 janv. 2007 - Food and Drug Administration Amendments Act of 2007
Description:
Specifically authorized FDA to require manufacturers post-marketing clinical studies to monitor for risks infected during the pre-market approval processAlso required REMS programs where necessary. What is a REMS program?
Ajouté au bande de temps:
Date:
1 janv. 2007
Maintenaint
~ Il y a 18 ans